lacosamide medical valley filmuhúðuð tafla 200 mg
medical valley invest ab - lacosamidum inn - filmuhúðuð tafla - 200 mg
lacosamide medical valley filmuhúðuð tafla 50 mg
medical valley invest ab - lacosamidum inn - filmuhúðuð tafla - 50 mg
lacosamide accord
accord healthcare s.l.u. - lacosamíð - flogaveiki - antiepileptics, - lacosamide accord is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. lacosamide accord is indicated as adjunctive therapy• in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy. • in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
lacosamide ucb
ucb pharma s.a. - lacosamíð - flogaveiki, partial - antiepileptics, - lacosamide ucb er ætlað eitt og sér og venjulega meðferð í meðferð á hluta-upphaf flog með eða án efri almenn ákvörðun er tekin í fullorðnir, unglingum og börn, frá 4 ára aldri með flogaveiki.
lacosamide adroiq
extrovis eu ltd. - lacosamíð - flogaveiki - antiepileptics, - lacosamide adroiq is indicated as monotherapy in the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. lacosamide adroiq is indicated as adjunctive therapyin the treatment of partial-onset seizures with or without secondary generalisation in adults, adolescents and children from 2 years of age with epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
vimpat
ucb pharma sa - lacosamíð - flogaveiki - antiepileptics, - vimpat er ætlað sem einlyfjameðferð og viðbótarmeðferð við meðhöndlun á flogaveiki með eða án aukakvilla hjá fullorðnum, unglingum og börnum frá 4 ára með flogaveiki.
ontozry
angelini pharma s.p.a - cenobamate - flogaveiki - antiepileptics, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.